Most Clicked StoriesMore >


First human trials of new Ebola vaccine underway in Md.

FDLI SmartBrief | Oct 16, 2014

Tests of a vaccine developed by Canada's Public Health Agency began this week at the Walter Reed Army Institute of Research in Maryland. Another vaccine is being developed by GlaxoSmithKline. Other promising potential therapies include blood transfusions from survivors, antiviral drugs, antibody drugs and treatments that could stop the virus from reproducing. USA Today (10/15)


FDA seeks better drug quality with restructuring

FDLI SmartBrief | Oct 17, 2014

Absence of Ebola vaccine not caused by budget cuts, health official says

FDLI SmartBrief | Oct 20, 2014

Upton's omnibus bill may change FDA oversight of pharma communications

FDLI SmartBrief | Oct 17, 2014

U.S. country of origin labeling rules rejected by WTO

FDLI SmartBrief | Oct 21, 2014

Curb soaring prices of generic meds, 2 lawmakers urge HHS

FDLI SmartBrief | Oct 20, 2014

FDA issues draft guidance on development of migraine drugs

FDLI SmartBrief | Oct 22, 2014

Parkinson's drug tied to risk of impulse control disorders

FDLI SmartBrief | Oct 21, 2014

Idiopathic pulmonary fibrosis drugs from Roche, Boehringer win FDA approval

FDLI SmartBrief | Oct 16, 2014

Study: Lack of enforcement lets recalled supplements stay on market

FDLI SmartBrief | Oct 22, 2014


Find FDLI SmartBrief Issues by Date:



FDLI News More >


Early bird ends Nov. 3! Food and Drug Law and Regulation, 3rd Edition

FDLI SmartBrief | Oct 23, 2014

Enforcement, Litigation and Compliance Conference -- Holiday Reception and Leadership Awards

FDLI SmartBrief | Oct 23, 2014

Join Us on Dec. 11-12 for Our Introduction to Drug Law and Regulation Conference!

FDLI SmartBrief | Oct 22, 2014

Spotlight panel: Quality Control Issues in the U.S. and EU -- Drugs and Devices -- Brussels Conference, Nov. 13-14

FDLI SmartBrief | Oct 22, 2014

Enforcement, Litigation, and Compliance -- what do you do when the FDA shows up at your door?

FDLI SmartBrief | Oct 21, 2014




Sign up for FDLI SmartBrief



Designed specifically for professionals involved in the food and drug law community, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition. Learn more

Recent Poll view more polls


What affect do you think this year's media focus on imported drug, food and medical device product safety will have in 2010?

Chart.